首页 | 本学科首页   官方微博 | 高级检索  
检索        

哒嗪酮类新衍生物的合成及其对血小板聚集的抑制作用
引用本文:王曙东,陈兴东,赵庆杰,邹燕,胡宏岗,俞世冲,汪亭,柴晓云,任海祥.哒嗪酮类新衍生物的合成及其对血小板聚集的抑制作用[J].药学实践杂志,2011,29(5):362-365.
作者姓名:王曙东  陈兴东  赵庆杰  邹燕  胡宏岗  俞世冲  汪亭  柴晓云  任海祥
作者单位:1. 南京军区南京总医院,江苏南京,210002
2. 第二军医大学药学院,上海,200433
基金项目:上海市科委课题 (20054Y1700).
摘    要:目的研究引入取代仲胺类基团对6-(4-取代乙酰氨基苯基)-5-甲基-4,5-二氢-3(2H)-哒嗪酮类化合物抗血小板凝集活性的影响。方法设计合成未见报道的目标化合物10个,所有化合物均经过1H-NMR谱等确证;参考文献方法进行体外药理实验。结果所有化合物都具有抗血小板凝集的活性,其中化合物9c,9f和9j的抗血小板凝集活性明显优于对照药MCI-154和CCI-17910。结论取代仲胺基团的空间位阻和亲水性对化合物抗血小板凝集的活性有影响。

关 键 词:合成  哒嗪酮类  体外抗血小板聚集  体外活性
收稿时间:2011/5/10 0:00:00
修稿时间:2011/8/26 0:00:00

Synthesis and platelet aggregation inhibition activity of new derivatives of pyridazinone
WANG Shu-dong,CHEN Xing-dong,ZHAO Qing-jie,ZOU Yan,HU Hong-gang,YU Shi-chong,WANG Ting,CHAI Xiao-yun and REN Hai-xiang.Synthesis and platelet aggregation inhibition activity of new derivatives of pyridazinone[J].The Journal of Pharmaceutical Practice,2011,29(5):362-365.
Authors:WANG Shu-dong  CHEN Xing-dong  ZHAO Qing-jie  ZOU Yan  HU Hong-gang  YU Shi-chong  WANG Ting  CHAI Xiao-yun and REN Hai-xiang
Institution:The Nanjing General Hospital of Nanjing Military Command, Nanjing 210002, China;The Nanjing General Hospital of Nanjing Military Command, Nanjing 210002, China;School of pharmacy, Second Military Medical University, Shanghai, 200433, China;School of pharmacy, Second Military Medical University, Shanghai, 200433, China;School of pharmacy, Second Military Medical University, Shanghai, 200433, China;School of pharmacy, Second Military Medical University, Shanghai, 200433, China;School of pharmacy, Second Military Medical University, Shanghai, 200433, China;School of pharmacy, Second Military Medical University, Shanghai, 200433, China;The Nanjing General Hospital of Nanjing Military Command, Nanjing 210002, China
Abstract:Objective To study the antiplatelet aggregative activity of 6-(4-substitued acetamino-phenyl 4, 5-dihydro-3(2H)-pyridazinones with different substituted secondary amines. Methods Ten target compounds were designed and synthesized.All of them were confirmed by 1H-NMR spectra. Born method was applied for preliminary pharmacological test in vitro. Results All of the target compounds were not reported.The results of preliminary pharmacological test showed that all the target compounds exhibited potent anti-platelet aggregative activity to a certain extent.Compounds 9c, 9f and 9j were better than MCI-154 and CCI-17910 in vitro. Conclution The steric hindrance and hydrophilicity of different substituted secondary amines impact the anti-platelete aggative activity.
Keywords:synthesis  pyridaziones  platelet aggregation in vitro
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号